Generative AI applications in Pharmaceuticals Medical Affairs

<p style="text-align: justify;">I have been impressed by the recent spike in use cases of Generative AI applications for the Medical Affairs organizations in pharmaceutical companies, and shall like to share some observations.</p><p style="text-align: justify;">Scientific engagement data, as well records of scientific leaders&rsquo; clinical / research activities, both syndicated and/or directly managed by the pharma companies, are ingested into Generative AI machines to produce insights guiding Medical Affairs in their understanding of key opinion leaders&rsquo; priorities and helping developing relevant dialogues with the medical scientific community.</p><p style="text-align: justify;">By reducing dense scientific knowledge into digestible summaries and abstracts, AI technology- in particular, Natural Language Generation (NLG) - offers a means of improving efficiency and relevance in medical affairs endeavours.</p><p style="text-align: justify;">&nbsp;</p><h2 style="text-align: justify;"><span style="font-size: 14pt;"><strong>Gen AI leveraging scientific engagement data sources</strong></span></h2><p style="text-align: justify;">In their frequent interactions with scientific leaders and healthcare providers, medical affairs staff members&mdash;like medical scientific liaisons&mdash;capture unstructured data using a variety of systems, including Customer Relationship Management (CRM) applications or peer-to-peer social platforms. These exchanges produce information that generative AI may improve and examine to surface insights.</p><p style="text-align: justify;"><strong>Enhancing Unstructured Data</strong></p><p style="text-align: justify;">Natural language processing methods are used by generative AI systems to handle unstructured data inputs, such as notes from interactions and discussions. Subsequently, they establish a connection between this data and metadata, which comprises keywords and classification schemes that are extracted from the discussions. The AI system organises these inputs into themes or patterns based on its analysis of the emerging subjects.</p><p style="text-align: justify;"><strong>Identify Themes and Patterns</strong></p><p style="text-align: justify;">After these topics are recognised, the AI system may track remarks and detect significant statements made during conversations to gauge attitudes and patterns among medical practitioners. As time goes on, the system could identify new topics and provide summaries of unseen or complex views. Healthcare providers and medical affairs personnel may then interact and communicate more effectively due to these insights.</p><p style="text-align: justify;">To summarise, generative artificial intelligence (AI) empowers pharmaceutical firms to derive practical conclusions from scientific engagement data, hence promoting well-informed decision-making and augmenting the effectiveness of medical affairs activities.</p><p style="text-align: justify;">&nbsp;</p><h2 style="text-align: justify;"><span style="font-size: 14pt;"><strong>Developing and Implementing Gen AI applications for Medical Affairs</strong></span></h2><p style="text-align: justify;">Harnessing the potential of generative AI in medical affairs requires bridging the knowledge gap between data scientists, regulatory experts, industry stakeholders, and healthcare professionals. The path to successful collaboration demands a seamless fusion of interdisciplinary methods due to strict compliance standards and ethical concerns.</p><p style="text-align: justify;">A balanced approach is crucial in the field of medical affairs, where scientific interactions are closely examined for compliance and integrity. Every encounter, from regulatory evaluations to internal compliance controls, is carefully examined. This picture is becoming further complicated by the rise of generative AI, hence the call for collaborative models to guarantee compliance with increasingly complex ethical and legal requirements.</p><p style="text-align: justify;">It is crucial to adopt collaborative models that surpass professional barriers in order to effectively navigate the medical scientific exchange domain. By working together, data scientists, industry stakeholders, regulatory specialists, and healthcare professionals can develop balanced and accurate Gen AI system to produce and disseminate medical information , encouraging therapeutical innovation and improving patient care.</p><p style="text-align: justify;">&nbsp;</p><h2 style="text-align: justify;"><span style="font-size: 14pt;"><strong>Strategies to Leverage Gen AI in Pharmaceutical Companies&nbsp;</strong></span></h2><p style="text-align: justify;">Pharmaceutical companies are getting aggressively involved in the implementation of Gen AI applications for medical affairs, ranging from increasing internal personnel productivity to transforming and optimizing the production of medical content. To name a few of those increasingly popular Gen AI applications, we would highlight training of medical affairs staff and the automated answering to medical inquiries from health care professionals.</p><p style="text-align: justify;">Larger corporations seem choosing to develop themselves end-to-end solutions, whereas mid-sized businesses combine their own AI models with already established technologies supplied by vendors. In an attempt to gain a competitive advantage, some pharmaceutical companies form alliances with IT companies active in the AI field in order to carve out a niche in&nbsp;specialised therapeutical areas. Whether building or purchasing an AI-driven medical affairs eco-system, the companies&rsquo; objective remains the same: to break new ground and secure a first-mover advantage in driving adoption by healthcare providers of novel treatments for medical conditions.</p><p style="text-align: justify;">In summary, pharmaceutical firms have the potential to significantly impact healthcare in the future, by using the transformational power of Gen AI through smart investments and creative collaborations.</p><p style="text-align: justify;">&nbsp;</p><p style="text-align: justify;"><strong>&nbsp;</strong></p><p style="text-align: justify;"><em>This article was contributed by our expert&nbsp;<a href="" target="_blank" rel="noopener">Paolo Mensitieri</a></em></p><p style="text-align: justify;">&nbsp;</p><p style="text-align: justify;">&nbsp;</p><h3 style="text-align: justify;"><span style="font-size: 18pt;">Frequently Asked Questions Answered by Paolo Mensitieri</span></h3><h2 style="text-align: justify;">&nbsp;</h2><h2 style="text-align: justify;"><span style="font-size: 12pt;"><strong>1. What are the key ethical considerations that arise when using Gen AI for medical affairs, and how can those concerns be addressed to ensure privacy, autonomy and informed consent?</strong></span></h2><p style="text-align: justify;">The ethical integrity of generative AI models is critical in the medical affairs domain, as biases can impede fair access to healthcare and perpetuate inequality in a variety of contexts, including the recruitment of patients for clinical trials and the dissemination of relevant scientific information.</p><p style="text-align: justify;">Medical affairs departments are at the forefront of this ethical dilemma, closely examining AI systems to make sure they are accurate and fair. Important concerns are brought up before implementation, such as: Will AI replies to medical or patient&nbsp;enquiries be ethically sound? Do they adhere to a balanced and scientific approach? As a result, the design stage of those AI systems takes on a crucial role, requiring algorithmic outputs to be transparent and auditable.</p><p style="text-align: justify;">Transparency cannot be compromised. Explainable AI is essential for thorough analyses and comprehension of algorithmic choices. From data intake to response production, every stage of the AI process needs to be transparent and justified.</p><p style="text-align: justify;">Moreover, data&nbsp;curation is essential. Datasets must be meticulously curated and verified to encompass diverse perspectives, mitigating bias and promoting unbiased outcomes.</p><p style="text-align: justify;">These factors act as guiding principles in the search for ethical AI, ensuring that medical affairs staff members use AI technologies safely and responsibly in the pursuit of improving healthcare equity for everyone.</p><p style="text-align: justify;">&nbsp;</p><h2 style="text-align: justify;"><span style="font-size: 12pt;"><strong>2. How do you envision the landscape of Gen AI adoption evolving in scientific evidence dissemination over the next decade? And what factors are likely to drive or inhibit its widespread adoption?</strong></span></h2><p style="text-align: justify;">Pharmaceutical organisations are entering a new age because to the transformational potential of generative AI, which can reduce complicated scientific material into practical insights and distribute them through reliable chatbots. With a logarithmic growth in these methods anticipated, attention turns to accuracy and ethical adherence.</p><p style="text-align: justify;">Ensuring that AI-generated outputs adhere to strict guidelines for ethical integrity and scientific correctness is a difficulty. In spite of unavoidable setbacks like training constraints and design defects, the important thing is to aim for achievement of&nbsp;pre-defined ethical objectives.</p><p style="text-align: justify;">In order to successfully complete this challenging&nbsp;endeavour, stakeholders must truly collaborate, combining their knowledge from other domains to jointly develop and improve AI models and tools. We can push Generative AI towards its ultimate aim of providing ethically sound, unbiased, and scientifically supported information to support advances in healthcare by improving the training process and encouraging inclusion of academia, business, and government agencies staff in the systems&rsquo; design process.</p><p style="text-align: justify;">&nbsp;</p><h2 style="text-align: justify;"><span style="font-size: 12pt;"><strong>3. How can Gen AI assist medical affairs teams in synthesizing and disseminating scientific evidence, clinical guidelines and medical literature to healthcare professionals?</strong></span></h2><p style="text-align: justify;">By utilising the capabilities of Generative AI, medical affairs organisations may optimise information synthesis procedures. Gen AI systems quickly provide customised solutions by automating the combination of internal data, such as queries from medical experts and updates from clinical trials, and condensing complicated material into brief summaries. Besides ensuring compliance, this automatic synthesis should always be presented in a balanced, relevant, and accurate format from a scientific standpoint.</p><p style="text-align: justify;">&nbsp;</p><p style="text-align: justify;">&nbsp;</p><p style="text-align: justify;">&nbsp;</p><p style="text-align: justify;">&nbsp;</p>
KR Expert - Paolo Mensitieri

Core Services

Human insights are irreplaceable in business decision making. Businesses rely on Knowledge Ridge to access valuable insights from custom-vetted experts across diverse specialties and industries globally.

Get Expert Insights Today